Aurobindo Pharma Shares Gain Even As Q3 Profit Sinks; Board Declares 300% Dividend

Pharma giant Aurobindo Pharma has announced an interim dividend of 300 per cent along with the December quarter results. The share of US business in the total business of the company has reached about 46.8%. Know the big things of Aurobindo Pharma's concall from Nupur.